Patent · US Active

Compositions and methods which modulate G-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis

US8569229B2 · kind B2 · utility

0Cited by
3References
8Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 9, 2010
Grant dateOct 29, 2013
Priority date—
Expiry dateApr 15, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/0073
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for the treatment of asthma and inflammatory ocular disorders are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.